Nabriva Therapeutics (NBRVF) Q1 2021 Earnings

6MayExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-1.11
-0.79
-0.46
-0.14

Details

Expected EPS
-0.67
Actual EPS
-0.53
Surprise EPS
0.14
Surprise Percent
+20.9%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.53 per share for Q1 2021.

0 Comments

Share your thoughts